weight regain after stopping glp-1 agonists Patients rapidly weight loss drugs – but still keep off a quarter of weight lost Those discontinuing GLP-1 medications rapidly
Description
The resulting payer policy cascade is converting an estimated 750 million previously untreated patients into commercially addressable prescription candidates

We conducted a search of the literature on 20 November 2023 via Ovid SP of PubMed/MEDLINE, Embase, Cochrane CENTRAL and PsycInfo databases from inception, updated with serial manual searches until 13 July 2024

doi: 10.1159/000330447 74 HegedsLShermanSITuttleRMvon ScholtenBJRasmussenSKarsblJDet al

GLP-1RAs, GLP-1 receptor agonists
